Correlation of baseline ENPP1 and cGAS expression in advanced solid tumors with intratumoral immune activation and clinical outcomes after treatment with the first-in-class oral ENPP1 inhibitor RBS2418, alone or in combination with pembrolizumab.

Thomas U. Marron, Jamal Misleh, Alexander I. Spira et al.|Journal of Clinical Oncology|2024

Cited by 3